 Receptors, Interleukin-2
"Receptors, Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
| Descriptor ID |
D015375
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.320
|
| Concept/Terms |
Receptors, Interleukin-2- Receptors, Interleukin-2
- Receptors, Interleukin 2
- TCGF Receptor
- TCGF Receptors
- Receptors, TCGF
- IL-2 Receptor
- IL 2 Receptor
- Receptor, IL-2
- IL-2 Receptors
- IL 2 Receptors
- T-Cell Growth Factor Receptor
- T Cell Growth Factor Receptor
- IL2 Receptors
- Receptors, IL2
- Interleukin 2 Receptor
- Receptor, Interleukin 2
- Interleukin-2 Receptors
- Interleukin 2 Receptors
- Receptor, TCGF
- Receptors, IL-2
- Receptors, IL 2
- Receptors, T-Cell Growth Factor
- Receptors, T Cell Growth Factor
- T-Cell Growth Factor Receptors
- T Cell Growth Factor Receptors
- IL2 Receptor
- Receptor, IL2
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-2".
This graph shows the total number of publications written about "Receptors, Interleukin-2" by people in this website by year, and whether "Receptors, Interleukin-2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 | | 1996 | 0 | 3 | 3 | | 1997 | 1 | 1 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 3 | 4 | | 2000 | 1 | 3 | 4 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 2 | 3 | | 2003 | 1 | 3 | 4 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 2 | 5 | | 2006 | 1 | 4 | 5 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-2" by people in Profiles.
-
Hsieh EW, Hernandez JD. Clean up by aisle 2: roles for IL-2 receptors in host defense and tolerance. Curr Opin Immunol. 2021 10; 72:298-308.
-
Schold J, Poggio E, Goldfarb D, Kayler L, Flechner S. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States. Transplantation. 2015 Jun; 99(6):1165-71.
-
Atif SM, Lee SJ, Li LX, Uematsu S, Akira S, Gorjestani S, Lin X, Schweighoffer E, Tybulewicz VL, McSorley SJ. Rapid CD4+ T-cell responses to bacterial flagellin require dendritic cell expression of Syk and CARD9. Eur J Immunol. 2015 Feb; 45(2):513-24.
-
Zachariah M, Gregg A, Schold J, Magliocca J, Kayler LK. Alemtuzumab induction in simultaneous pancreas and kidney transplantation. Clin Transplant. 2013 Sep-Oct; 27(5):693-700.
-
Abbate A, Van Tassell BW, Seropian IM, Toldo S, Robati R, Varma A, Salloum FN, Smithson L, Dinarello CA. Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J Heart Fail. 2010 Apr; 12(4):319-22.
-
Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev. 2008 Dec; 226:19-28.
-
Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett. 2007 Nov 30; 114(1):1-8.
-
Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006 Oct 01; 177(7):4488-94.
-
Weisman MH, Durez P, Hallegua D, Aranda R, Becker JC, Nuamah I, Vratsanos G, Zhou Y, Moreland LW. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2162-6.
-
Taylor DK, Walsh PT, LaRosa DF, Zhang J, Burchill MA, Farrar MA, Turka LA. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis. J Immunol. 2006 Aug 15; 177(4):2216-23.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|